Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Careers
Support The Mission
Support The Mission
Become a Member
Explore Different Ways to Give
Create a Legacy
Join IASLC's Partners for Thoracic Cancer Care
Recognizing Our Donors
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Access Online Learning
Conferences & Education
Conferences & Education
Conferences
Webinars
Courses
Online Learning: Lung Cancer 360
Lung Cancer Considered Podcast
WCLC 2024
Science & Research
Science & Research
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Research Grant Program
Research Grant Program
Research Grant Recipients
IASLC Academy
Publications, Resources & Guidelines
Membership
Membership
Become a Member
Renew Your Membership
Early-Career Opportunities
Partners Society Membership Offers
Patients & Caregivers
Patients & Caregivers
STARS Training
Lung Cancer Awareness Month
News
News
IASLC Lung Cancer News
WCLC 2024 News
Press Releases
Search
Fulltext search
Fulltext search
Search
Displaying 1 - 12 items out of 2158 results
Landing page
Call for Nominations for the 2023 IASLC Board of Directors Election Open Now Through January 25, 2023
Podcast
Lung Cancer Considered Introduces New Podcast Hosts
Podcast
Women In Thoracic Oncology
Press release
Selected Gene mRNA Expression Is Not Predictive of Improved Overall Survival Among Patients Undergoing Surgery for Stage II-III Lung Cancer
Press release
Sotorasib Provides Durable Clinical Benefit for Patients with NSCLC and KRAS Mutations
Press release
Adding Ipilimumab to Pembrolizumab Does Not Improve Efficacy in patients with NSCLC
Press release
LCMC3: Neoadjuvant Atezolizumab Safe, Meets Primary Endpoint of Pathologic Response Rate Prior to Lung Cancer Surgery
Press release
Nivolumab Effective Treatment for Malignant Mesothelioma
Press release
TALENT Study Supports NLCST and NELSON Trial Results
Landing page
World Conference on Lung Cancer 2020 News
Landing page
Donate
Landing page
Journals
Pagination
1
2
3
4
5
6
7
8
9
…
›
Next page
Last
Last page